POSEIDA THERAPEUTICS INC shareholders Q2 2024

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 93 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

POSEIDA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,607,999$10,535,3572.49%
Aisling Capital Management LP 1,043,267$3,046,3401.32%
Boxer Capital, LLC 4,475,000$13,067,0000.69%
Octagon Capital Advisors LP 736,000$2,149,1200.34%
Pentwater Capital Management LP 5,975,000$17,447,0000.22%
Atom Investors LP 395,768$1,155,6430.12%
MCF Advisors LLC 247,024$721,3110.06%
Forefront Analytics, LLC 29,817$87,0650.04%
CORNERCAP INVESTMENT COUNSEL INC 79,223$231,3310.04%
XTX Topco Ltd 124,301$362,9590.03%
CANTOR FITZGERALD, L. P. 50,205$146,5990.03%
Callan Capital, LLC 84,080$245,5140.02%
Keystone Financial Group 15,000$43,8000.02%
RBF Capital, LLC 70,171$204,8990.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 927,006$2,706,8580.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 143,600$419,3120.01%
BLAIR WILLIAM & CO/IL 1,101,325$3,215,8690.01%
Dynamic Technology Lab Private Ltd 27,031$790.01%
Renaissance Technologies 854,900$2,496,3080.00%
ACADIAN ASSET MANAGEMENT LLC 399,839$1,1650.00%
External links

This page lists POSEIDA THERAPEUTICS INC's shareholders in Q2 2024. To view POSEIDA THERAPEUTICS INC's shareholder history, click here.